Episcleritis: Difference between revisions

Line 7: Line 7:


==Clinical Features==
==Clinical Features==
*History
[[File:Episcleritiseye.jpg|thumb|Episcleritis]]
** Abrupt onset of redness, irritation, and watering of the eye
===History===
** Pain is unusual
* Abrupt onset of redness, irritation, and watering of the eye
** Vision unaffected
* Pain is unusual
** 50% of cases are bilateral
* Vision unaffected
*Physical exam
* 50% of cases are bilateral
**Vasodilatation of the superficial episcleral vessels
 
**Focal area(s) of redness  
===Physical exam===
**May have a tender scleral nodule (nodular episcleritis)
*Vasodilatation of the superficial episcleral vessels
*Focal area(s) of redness  
*May have a tender scleral nodule (nodular episcleritis)


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 15:05, 8 November 2015

Background

  • Abrupt onset of inflammation in the episclera
  • 70% of cases occurs in women (usually young/middle-aged)
  • Usually a benign, self-limited condition
  • Can be classified into simple (more common) or nodular types
  • Most commonly idiopathic but may occur as an ocular manifestation of underlying autoimmune conditions eg RA, IBD

Clinical Features

Episcleritis

History

  • Abrupt onset of redness, irritation, and watering of the eye
  • Pain is unusual
  • Vision unaffected
  • 50% of cases are bilateral

Physical exam

  • Vasodilatation of the superficial episcleral vessels
  • Focal area(s) of redness
  • May have a tender scleral nodule (nodular episcleritis)

Differential Diagnosis

Diagnosis

  • Must distinguish from scleritis
    • Scleritis likely to have pain and decreased vision
    • Use of 2.5% phenylephrine drops will cause vasoconstriction/blanching of episcleral but not scleral vessels. Thus, there will be decreased injection and redness in episcleritis but not scleritis.[1]
  • Must distinguish from conjunctivitis
    • Episcleritis will usually have a sectoral pattern of injection, as opposed to a diffuse injection seen in conjunctivitis.

Management

  • Topical lubricants
    • Artificial tears q4-6hr
  • Oral NSAIDs

Disposition

  • Refer to ophtho is unsure of diagnosis or if steroids are necessary for Tx
  • Self-limiting (will resolve within 2-3 weeks)

See Also

External Links

References

  1. Mahmood AR, Narang AT. Diagnosis and management of the acute red eye. Emerg Med Clin North Am 2008; 26:35-55.